Jan 13, 2021 / 02:10PM GMT
Richard Vosser - JPMorgan Chase & Co, Research Division - Senior Analyst
Good morning, and good afternoon to everyone. Welcome to the 39th JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst at JPMorgan. And it gives me great pleasure to introduce Rodolfo Savitzky, CFO of Lonza, to this presentation.
Before I hand over to Rodolfo, I remind you that if you would like to ask a question during the Q&A portion of this session, then you can use the Q&A function at any time to submit your question and then I will ask your question at the appropriate time.
With that, I'd like to say a big warm welcome to Rodolfo. Rodolfo, over to you.
Rodolfo J. Savitzky - Lonza Group Ltd - CFO
Thank you, Richard. Good morning, good afternoon. The fact that we are having our JPMorgan Conference virtual is a reminder of the dramatic impact the COVID pandemic has had on the world and on all of us, but this pandemic has also challenged us to work in ways we didn't think possible before. So in May 2020, we signed a strategic
Lonza Group AG at JPMorgan Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot